Medicare Enrolled
Dr. John Kritsas, M.D.
Optician · Hinsdale, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kritsas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kritsas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kritsas
Dr. John Kritsas is an optician specialist in Hinsdale, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kritsas performed 5,913 Medicare services across 2,650 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kritsas received a total of $8,040 from 65 pharmaceutical and/or device companies across 389 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kritsas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 9% volume in IL
$8,040 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,913
Medicare services
Top 9% in IL for optician
2,650
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~296 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Leuprolide injectable, camcevi, 1 mg | 1,218 | $64 | $150 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,027 | $3 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
937 | $94 | $228 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
804 | $8 | $20 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
460 | $8 | $100 |
| Antimicrobial drug evaluation Assessment of the patient's response to antibiotic, antifungal, or antiviral therapy. |
226 | $7 | $30 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
225 | $2 | $20 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
222 | $8 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
198 | $72 | $163 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
114 | $202 | $930 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
79 | $51 | $340 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 72 | $122 | $1,917 |
| Insertion of temporary bladder tube | 61 | $36 | $270 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
61 | $136 | $324 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
46 | $26 | $160 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
38 | $6 | $240 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $48 | $103 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $125 | $302 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
18 | $64 | $380 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
18 | $206 | $1,010 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
17 | $117 | $590 |
| New patient office visit, complex (60-74 min) | 14 | $173 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,040
Total received (2018-2024)
Avg $1,149/year across 7 years
Top 12% in IL for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
389
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,401 (92.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$640 (8.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,162
2023
$1,198
2022
$1,251
2021
$1,297
2020
$300
2019
$1,158
2018
$1,674
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$244
Dendreon Pharmaceuticals LLC
$142
Bayer Healthcare Pharmaceuticals Inc.
$136
ABBVIE INC.
$120
Blue Earth Diagnostics Limited
$79
PFIZER INC.
$59
LANTHEUS MEDICAL IMAGING, INC.
$52
Janssen Biotech, Inc.
$50
Merck Sharp & Dohme LLC
$49
Tempus AI, Inc
$46
Novartis Pharmaceuticals Corporation
$43
Myriad Genetic Laboratories, Inc.
$37
ACCORD HEALTHCARE, INC.
$37
Otsuka America Pharmaceutical, Inc.
$26
Teleflex LLC
$22
Tolmar, Inc.
$20
Top 3 companies account for 45.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,909
PFIZER INC.
$580
Dendreon Pharmaceuticals LLC
$461
Janssen Biotech, Inc.
$441
ABBVIE INC.
$435
Bayer HealthCare Pharmaceuticals Inc.
$321
Blue Earth Diagnostics Limited
$218
AbbVie, Inc.
$211
MEDIVATION FIELD SOLUTIONS LLC
$208
Bayer Healthcare Pharmaceuticals Inc.
$197
Endo Pharmaceuticals Inc.
$186
Merck Sharp & Dohme LLC
$165
Myriad Genetic Laboratories, Inc.
$165
Coloplast Corp
$140
Avadel Specialty Pharmaceuticals, LLC
$139
Antares Pharma, Inc.
$136
Myovant Sciences Inc.
$123
TOLMAR Pharmaceuticals, Inc.
$118
Novartis Pharmaceuticals Corporation
$103
AbbVie Inc.
$99
SANOFI-AVENTIS U.S. LLC
$90
Mission Pharmacal Company
$84
Sumitomo Pharma America, Inc.
$79
AstraZeneca Pharmaceuticals LP
$74
Ferring Pharmaceuticals Inc.
$69
Merck Sharp & Dohme Corporation
$68
UROVANT SCIENCES INC
$66
COLOPLAST CORP
$65
Allergan, Inc.
$64
GENZYME CORPORATION
$54
ACCORD HEALTHCARE, INC.
$53
LANTHEUS MEDICAL IMAGING, INC.
$52
Olympus America Inc.
$47
Tempus AI, Inc
$46
Progenics Pharmaceuticals, Inc.
$41
Accord Healthcare, Inc.
$41
Tolmar, Inc.
$39
Foundation Medicine, Inc.
$39
Supernus Pharmaceuticals, Inc.
$38
Zyla Life Sciences
$37
Aytu BioScience, Inc
$33
Clarus Therapeutics Inc.
$33
Retrophin, Inc.
$32
AMAG Pharmaceuticals, Inc.
$30
Prometheus Laboratories Inc.
$29
Amgen Inc.
$27
Otsuka America Pharmaceutical, Inc.
$26
Ambu Inc.
$25
Travere Therapeutics, Inc.
$25
Allergan Inc.
$23
Rochester Medical Corporation
$22
Teleflex LLC
$22
PROCEPT BioRobotics Corporation
$20
Verity Pharmaceuticals Inc.
$19
Boston Scientific Corporation
$19
Lumenis, Inc
$18
Alnylam Pharmaceuticals Inc.
$18
Egalet US Inc
$18
NeoTract Inc.
$16
Sun Pharmaceutical Industries Inc.
$16
ConvaTec Inc.
$15
UroGen Pharma, Inc.
$15
Kowa Pharmaceuticals America, Inc.
$15
DENTSPLY IH Inc.
$14
AKRIMAX PHARMACEUTICALS, LLC
$14
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM ROBOTIC SYSTEM · Androgel · Axumin · BOTOX · CAMCEVI · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL KIDNEY STONE DISEASE · GentleCath · INTRAROSA · JATENZO · JELMYTO · JEVTANA · JYNARQUE · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lumenis Pulse 120H · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · Olympus Laser Devices · Otrexup · PLUVICTO · POSLUMA · PREMARIN · PROLARIS · PROVENGE · PVC · PYLARIFY · Prolaris · Proleukin · Prolia · SEGLENTIS · SPEEDICATH · SPRIX · SUTENT · SpeediCath · Stendra · Synthroid · TLANDO · TOVIAZ · Titan · Trelstar · URIBEL · UROLIFT · Uribel · UroLift · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
901
Per 100K population
97.2
County median income
$110,502
Nearest hospital
UCHICAGO MEDICINE ADVENTHEALTH HINSDALE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kritsas is a clinical cardiology specialist, with above-average Medicare volume (top 9% in IL), with low-engagement industry engagement in the top 12% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kritsas experienced with leuprolide injectable, camcevi, 1 mg?
Based on Medicare claims data, Dr. Kritsas performed 1,218 leuprolide injectable, camcevi, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kritsas receive payments from pharmaceutical companies?
Yes. Dr. Kritsas received a total of $8,040 from 65 companies across 389 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kritsas's costs compare to other opticians in Hinsdale?
Dr. Kritsas's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kritsas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Hinsdale
Browse opticians in Hinsdale ranked by procedure volume and transparency data.
Highest volume
Top Opticians in IL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in IL
Which IL opticians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology